Overview

This trial is designed to evaluate the efficacy and safety of moxibustion plus cupping in the convalescence of COVID-19.

Eligibility

Inclusion Criteria:

1. Clinical diagnosis of the convalescence of COVID-19 (defined by the Chinese Guideline for COVID-19 in 2020 Trial Version 7).
2. 18-70 years old;
3. Cough / chest tightness / shortness of breath / asthenia after exercise, with at least 2 of the above symptoms and the average VAS score (last 48 hours) 40 points;
4. Volunteers with informed consent;
5. In the past 1 week, CT showed that there was still inflammation or pulmonary fibrosis in the lung, or the oxygen saturation95% without inhaling oxygen, or the walking distance of the six-minute-walking test 350 meters, with one of the above criteria;

Exclusion Criteria:

1. Surgery in the lung that affects lung function;
2. Rely on mechanical ventilation to maintain lung function;
3. Chronic lung diseases affecting lung function;
4. Diseases affecting heart function;
5. Severe basic diseases;
6. Resting heart rate > 120/min, systolic blood pressure > 180mmHg, diastolic blood pressure > 100mmHg;
7. Unstable angina or myocardial infarction in the past 1 month;
8. Severe obesity (BMI>30kg/m2);
9. Allergic constitution;
10. Pregnant or lactating women;
11. Disabled patients;
12. Mentally ill Patients;
13. Participating in other clinical trials;
14. Poor compliance or other complicate conditions according to the researchers.